Insulet Financial Ratios
NASDAQ: PODDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insulet ratio analysis
Insulet earned a net margin of 9.1% in FY 2025, down from 20.2% a year earlier. Gross margin was 71.6% compared with a median of 65.1% over the prior 9 years. Return on equity reached 16.3%, meaning Insulet generated 0.16 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.63 versus 1.14 the year before, and the current ratio was 2.81. At the end of FY 2025, PODD traded at 81.3 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 46.1 to 4205.6, with a median of 1005.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Insulet financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 81.30 | 46.07 | 73.80 | 4,205.57 | 1,108.63 | 2,556.30 | 902.53 | 1,543.00 | — | — |
| Price / sales | 7.35 | 9.01 | 8.92 | 15.65 | 16.39 | 18.30 | 14.08 | 8.05 | 8.63 | 5.88 |
| Price / book | 13.14 | 15.40 | 20.66 | 42.87 | 32.38 | 27.42 | 136.90 | 21.41 | 25.25 | 34.19 |
| Gross margin | 71.6% | 69.8% | 68.3% | 61.7% | 68.4% | 64.4% | 65.1% | 65.7% | 59.8% | 57.5% |
| Operating margin | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% | 5.7% | 6.8% | 4.9% | -1.6% | -2.9% |
| Net margin | 9.1% | 20.2% | 12.2% | 0.4% | 1.5% | 0.8% | 1.6% | 0.6% | -5.8% | -7.9% |
| Free cash flow margin | 13.9% | 14.7% | 4.1% | -0.3% | -16.4% | -5.0% | -8.8% | -21.6% | -7.0% | -1.7% |
| Return on equity (ROE) | 16.3% | 34.5% | 28.2% | 1.0% | 3.0% | 1.1% | 15.3% | 1.6% | -16.9% | -45.8% |
| Return on assets (ROA) | 7.7% | 13.5% | 8.0% | 0.2% | 0.8% | 0.4% | 1.0% | 0.4% | -3.3% | -6.3% |
| Debt / equity | 0.63 | 1.14 | 1.93 | 2.94 | 2.29 | 1.75 | 11.70 | 2.79 | 3.57 | 5.27 |
| Current ratio | 2.81 | 3.58 | 3.51 | 3.60 | 5.81 | 6.01 | 3.75 | 3.99 | 6.24 | 6.64 |
| Revenue growth | 30.7% | 22.1% | 30.0% | 18.8% | 21.5% | 22.5% | 30.9% | 21.6% | 26.4% | 39.1% |
| EPS growth | -39.8% | 96.6% | 4,100.0% | -70.8% | 140.0% | -47.4% | 280.0% | — | — | — |